BeyondSpring Inc.

BYSI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2024 Mar 2024
Revenue $0 $0
Cost of Revenue — —
Gross Profit — —
Gross Margin — —
Operating Expenses
Research & Development $829.0K $721.0K
SG&A Expense $1.8M $1.3M
Operating Income $-2.6M $-2.1M
Operating Margin — —
Interest Expense — —
Pretax Income $-2.7M $-2.1M
Income Tax Expense $0 $0
Net Income $-4.0M $-3.2M
Net Margin — —
EPS (Basic) $-0.10 $-0.08
EPS (Diluted) $-0.04 —
Shares Outstanding (Basic) 39.3M 39.0M
Shares Outstanding (Diluted) 39.3M 39.0M
Dividends Per Share — —
← Newer Page 2 of 2 Older →